Apomorphine Nasal Powder in the Treatment of Parkinson's Disease "Off" Periods.

NCT00346827 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

36

Enrollment

INDUSTRY

Sponsor class

Conditions

Parkinson's Disease

Interventions

DRUG: Apomorphine Nasal Powder

Sponsor

Britannia Pharmaceuticals Ltd.